Review Article
ErbB Proteins as Molecular Target of Dietary Phytochemicals in Malignant Diseases
Table 6
Bioavailability of curcumin.
| Species | Route | Dose | Plasma/tissue | | AUC | Ref |
| Rat | i.v. | 25 mg/kg | Liver | NA | 9.06 ± 1.55 min⋅g/mL | [133] | Heart | NA | 3.03 ± 0.85 min⋅g/mL | Spleen | NA | 5.72 ± 1.14 min⋅g/mL | Lung | NA | 8.98 ± 1.82 min⋅g/mL | Kidney | NA | 12.0 ± 0.88 min⋅g/mL | Brain | NA | 4.04 ± 0.22 min⋅g/mL | Rat | Oral | 50 mg/kg | Plasma | 13.0 ± 5.8 ng/mL | 51.1 ± 25 min⋅g/mL | [151] | 300 mg/kg | Plasma | 37.4 ± 36.1 ng/mL | 134 ± 114 min⋅g/mL | Rat | Oral | 1 g/kg | Plasma | 258.64 ng/mL | 2483.32 h⋅ng/mL | [134] | Human | Oral | 30 mg/kg | Plasma | 1.8 ± 2.8 ng/mL | 4.1 ± 7 h⋅ng/mL | [151] | Human | Oral | 10 g | Plasma | 50.5 ng/mL | NA | [132] | 12 g | Plasma | 57.6 ng/mL | NA |
|
|
i.v.: intravenous; i.g.: intragastric; , maximum concentration; AUC, area under the curve; NA, not applicable.
|